Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma
Lung Cancer: Targets and Therapy · 2024-10 · Volume 15 · 161-167
DOI: 10.2147/lctt.s490942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer: Targets and Therapy, 2024-10. Verfasst von Faustine X Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California Irvine School of Medicine, Orange, CA, 92868, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of California Irvine School of Medicine, Orange, CA, 92868, USA.
- Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USA.
ORCID-Profile: Zhaohui Liao Arter
Zitieren
APA
Luo, F. X., & Arter, Z. L. (2024). Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma. Lung Cancer: Targets and Therapy, Volume 15, 161-167. https://doi.org/10.2147/lctt.s490942
Vancouver
Luo FX, Arter ZL. Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma. Lung Cancer: Targets and Therapy. 2024;Volume 15:161-167. doi:10.2147/lctt.s490942
BibTeX
@article{Luo2024,
author = {Luo, Faustine X and Arter, Zhaohui Liao},
title = {Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma},
journal = {Lung Cancer: Targets and Therapy},
year = {2024},
volume = {Volume 15},
pages = {161--167},
doi = {10.2147/lctt.s490942}
}
EUVIMED